95 results
Page 3 of 5
8-K
EX-99.1
wwv36wvy f2ynwj
5 Feb 21
Regulation FD Disclosure
5:17pm
8-K
EX-99.1
se9k7
5 Jan 21
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
m9u4yksxgko dbpqo6
6 Nov 20
Regulation FD Disclosure
8:05am
8-K
EX-99.1
415iojz
20 Oct 20
Results of Operations and Financial Condition
9:16am
8-K
EX-99.1
86z0dhr122az
17 Aug 20
Regulation FD Disclosure
9:16am
424B5
qn2jlku5onq2jp35 gb
14 Aug 20
Prospectus supplement for primary offering
9:28pm
8-K
EX-99.1
22asclbh0ftx0b3dp mm
16 Jul 20
Results of Operations and Financial Condition
9:17am
424B5
p2lm0bdb
12 Jun 20
Prospectus supplement for primary offering
4:35pm
8-K
EX-99.1
fhgmp595
1 Jun 20
Other Events
9:23am
424B5
o0p zu8ja5fr
8 May 20
Prospectus supplement for primary offering
9:26am
8-K
EX-99.1
s7hgac
14 Feb 20
Regulation FD Disclosure
8:00am
8-K
s9d4z2
3 Jan 20
Departure of Directors or Certain Officers
4:45pm
8-K
EX-99.1
ww7rx9s
10 Dec 19
Ocugen Announces Completion of 50% of Enrollment of its Phase 3 Clinical Trial for ocular GVHD
8:30am
8-K
EX-99.1
cq4 ghd9v
26 Nov 19
Regulation FD Disclosure
5:16pm